Abstract
We evaluated long-term psychosocial consequences of predictive genetic testing, and surveillance behaviour in Lynch syndrome (LS). We conducted a longitudinal study of 208 participants (62 LS mutation carriers and 146 non-carriers) who provided information on general anxiety (State-Trait Anxiety Inventory), fear of cancer and dying, satisfaction with life, risk and test perceptions, and surveillance behaviour in the baseline questionnaire before testing, and 1 month, 1 year and 7 years post-test. At 7 years, most of the psychosocial variables remained unchanged, regardless of mutation status. Carriers tended to underestimate their colorectal cancer risk but were more worried about their cancer risk than their counterparts. Non-carriers reported a higher degree of satisfaction with their testing decisions (P < 0.05), but had more doubts concerning test result validity than carriers (P < 0.05). All carriers attended a post-test colonoscopy surveillance, while 16 % of non-carriers reported colonoscopy examinations. Those non-carriers with doubts about test validity were more likely (P = 0.019) to report post-test colonoscopy. Of the carriers, 17 % had an interval longer than 3 years between their colonoscopies. Fear of dying soon, measured at 1-month post-test follow-up was the only psychosocial variable predicting non-compliance in recommended surveillance. No adverse psychosocial consequences were detected, and respondents were satisfied with their decision to testing 7 years post-test. Among the carriers, solely fear of dying soon predicted non-compliance in recommended surveillance. Some non-carriers were still worried about their risk and had doubts about the validity of their genetic testing results predicting post-test colonoscopy.
Similar content being viewed by others
References
Lynch HT, de la Chapelle A (2003) Hereditary colorectal cancer. N Engl J Med 348:919–932
Vasen HF, Wijnen JT, Menko FH et al (1996) Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology 110:1020–1027
Aarnio M, Sankila R, Pukkala E et al (1999) Cancer risk in mutation carriers of DNA-mismatch-repair genes. Int J Cancer :214–218
Järvinen HJ, Renkonen-Sinisalo L, Aktan-Collan K et al (2009) Ten years after mutation testing for Lynch syndrome: cancer incidence and outcome in mutation-positive and mutation-negative family members. J Clin Oncol 27:4793–4797
Vasen HF, Abdirahman M, Brohet R, Langers AM, Kleibeuker JH, van Kouwen M, Koornstra JJ, Boot H, Cats A (2010) One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome. Gastroenterology 138(7):2300–2306
Lerman C, Hughes C, Trock BJ, Myers RE, Main D, Bonney A et al (1999) Genetic testing in families with hereditary nonpolyposis colon cancer. JAMA 281:1618–1622
Aktan-Collan K, Mecklin JP, Jarvinen H, Nystrom-Lahti M, Peltomaki P, Soderling I et al (2000) Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction. Int J Cancer 89:44–50
Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H (2001) Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study. Int J Cancer 93:608–611
Aktan-Collan K, Haukkala A, Mecklin JP, Uutela A, Kaariainen H (2001) Comprehension of cancer risk one and 12 months after predictive genetic testing for hereditary non-polyposis colorectal cancer. J Med Genet 11:787–792
Esplen MJ, Madlensky L, Butler K, McKinnon W, Bapat B, Wong J et al (2001) Motivations and psychosocial impact of genetic testing for HNPCC. Am J Med Genet 103:9–15
Hadley DW, Jenkins J, Dimond E, Nakahara K, Grogan L, Liewehr DJ et al (2003) Genetic counseling and testing in families with hereditary nonpolyposis colorectal cancer. Arch Intern Med 163:573–582
Arver B, Haegermark A, Platten U (2004) Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer 3:109–116
Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Legius E (2004) Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. Patient Educ Couns 55:265–274
Claes E, Denayer L, Evers-Kiebooms G, Boogaerts A, Philippe K, Tejpar S et al (2005) Predictive testing for hereditary nonpolyposis colorectal cancer: subjective perception regarding colorectal and endometrial cancer, distress, and health-related behavior at 1 year post-test. Genet Test 9:54–65
Gritz ER, Peterson SK, Vernon SW, Marani SK, Baile WF, Watts BG et al (2005) Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 23:1902–1910
Collins VR, Meiser B, Ukoumunne OC, Gaff C, St John DJ, Halliday JL (2007) The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: 3 years after testing. Genet Med 9:290–297
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH et al (2007) Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. Eur J Cancer 43:71–77
Shiloh S, Koehly L, Jenkins J, Martin J, Hadley D (2008) Monitoring coping style moderates emotional reactions to genetic testing for hereditary nonpolyposis colorectal cancer: a longitudinal study. Psycho-Oncology 17:746–755
Broadstock M, Michie S, Marteau T (2000) Psychological consequences of predictive genetic testing: a systematic review. Eur J Hum Genet 8:731–738
Meiser B, Collins V, Warren R, Gaff C, St John DJ, Young MA et al (2004) Psychological impact of genetic testing for hereditary non-polyposis colorectal cancer. Clin Genet 66:502–511
Meiser B (2005) Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology 14(12):1060–1074
Heshka JT, Pallechi C, Howley H, Wilson B, Welss PS (2008) A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med 10:19–32
Grover S, Stoffel EM, Mercado RC, Ford BM, Kohlman WK, Shannon KM, Conrad PG, Am Blanco, Terdiman JP, Gruber S, Chung DC, Syngal S (2009) Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol 27(24):3981–3986
Hadley DW, Jenkins JF, Dimond E, de Carvalho M, Kirsch I, Palmer CG (2004) Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. J Clin Oncol 22(1):39–44
Collins V, Meiser B, Gaff C, St John DJ, Halliday J (2005) Screening and preventive behaviors 1 year after predictive genetic testing for hereditary nonpolyposis colorectal carcinoma. Cancer 104:273–281
Gopie JP, Vasen HF, Tibben A (2012) Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?-A systematic review. Crit Rev Oncol Hematol 83(3):329–340
Hadley D, Ashida S, Jenkins J, Calzone K, Kirsch I, Koehly L (2011) Colonoscopy use following mutation detection in Lynch syndrome: exploring a role for cancer screening in adaptation. Clin Genet 79:321–328
Marteau TM, Weinman J (2006) Self-regulation and the behavioural response to DNA risk information: a theoretical analysis and framework for future research. Soc Sci Med 62(6):1360–1368
Michie S (2003) Understanding why negative genetic test results sometimes fail to reassure. Am J Med Genet 119A:340–347
Spielberger C, Gorsuch RL, Lushene R (1970) Manual for the state trait anxiety inventory. Consulting Psychologists Press, Palo Alto
Aro AR, Absetz SP, van den Elderen TM, van der Ploeg E, van der Kamp LJ (2000) False-positive findings in mammography screening induces short-term distress-breast cancer specific concern prevails longer. Eur J Cancer 36:1089–1097
van Oostrom I, Meijers-Heijboer H, Lodder LN, Duivenvoorden HJ, van Gool AR, Seynaeve C et al (2003) Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. J Clin Oncol 21(20):3867–3874
van Oostrom I, Meijers-Heijboer H, Duivenvoorden HJ, Brocker-Vriends AH, van Asperen CJ, Sijmons RH et al (2007) Comparison of individuals opting for BRCA1/2 or HNPCC genetic susceptibility testing with regard to coping, illness perceptions, illness experiences, family system characteristics and hereditary cancer distress. Patient Educ Couns 65(1):58–68
Acknowledgments
We thank Mrs. Tuula Lehtinen for her expert assistance. The study was supported by the Finnish Cancer Foundation and the Finnish-Norwegian Medical Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Aktan-Collan, K., Kääriäinen, H., Järvinen, H. et al. Psychosocial consequences of predictive genetic testing for lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study. Familial Cancer 12, 639–646 (2013). https://doi.org/10.1007/s10689-013-9628-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10689-013-9628-9